M/06/093 – Abbot/Kos Pharmaceutical
Transaction details
The proposed acquisition of Kos Pharmaceuticals, Inc. by Abbot Laboratories.
| Notification date | Decision date |
|---|---|
| Thursday December 14, 2006 | Friday, December 15, 2006 |
| Parties Involved | Business activities |
|---|---|
| Abbot Laboratories | Abbot is a broad-based health care company for the supply of pharmaceutical products and medical devices. |
| Kos Pharmaceuticals, Inc. | Kos is a speciality pharmaceutical company engaged in the develoment and commercialization of proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. |
| Economic sector | Media merger |
|---|---|
| Pharmaceutical sector | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Current status: Completed |
|---|
| Withdrawn |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Ibrahim Bah | 01-804 5425, ib@tca.ie |
Media enquiries: communications@ccpc.ie
Haven’t found what you’re looking for?
Scroll
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555